3
IRUS TotalDownloads
Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and Omicron variants in IBD patients following 3 doses of COVID-19 vaccine
File | Description | Size | Format | |
---|---|---|---|---|
![]() | Published version | 352.76 kB | Adobe PDF | View/Open |
Title: | Infliximab and tofacitinib attenuate neutralizing antibody responses against SARS-CoV-2 ancestral and Omicron variants in IBD patients following 3 doses of COVID-19 vaccine |
Authors: | Liu, Z Alexander, J LIN, K Pollock, K Powell, N |
Item Type: | Journal Article |
Issue Date: | Feb-2023 |
Date of Acceptance: | 12-Oct-2022 |
URI: | http://hdl.handle.net/10044/1/100121 |
DOI: | 10.1053/j.gastro.2022.10.010 |
ISSN: | 0016-5085 |
Publisher: | Elsevier |
Start Page: | 300 |
End Page: | 303.e3 |
Journal / Book Title: | Gastroenterology |
Volume: | 164 |
Issue: | 2 |
Copyright Statement: | © 2023 The Author(s). Published by Elsevier Inc. on behalf of the AGA Institute. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
Publication Status: | Published |
Online Publication Date: | 2022-10-19 |
Appears in Collections: | Department of Metabolism, Digestion and Reproduction Department of Surgery and Cancer Department of Infectious Diseases Faculty of Medicine Imperial College London COVID-19 |
This item is licensed under a Creative Commons License